NCT03503032

Brief Summary

Evaluation of fenestration benefit in Extra-cardiac total cavo-pulmonary connection (Fontan procedure) in single ventricle anomaly, comparing clinical outcomes of patients with low preoperative risk profiles in prospective study

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
62

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Apr 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 9, 2018

Completed
10 days until next milestone

First Posted

Study publicly available on registry

April 19, 2018

Completed
5 years until next milestone

Study Start

First participant enrolled

April 1, 2023

Completed
11 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 12, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 12, 2023

Completed
Last Updated

April 18, 2023

Status Verified

April 1, 2023

Enrollment Period

11 days

First QC Date

April 9, 2018

Last Update Submit

April 12, 2023

Conditions

Keywords

Extracardiac FontanTotal cavo-pulmonary connectionFenestratedCongenital heart defectsPediatrics

Outcome Measures

Primary Outcomes (1)

  • Duration of chest tube drainage

    Total duration of days patient has been having chest tube inserted in his pleural cavities

    through study completion, an average of 1 year

Secondary Outcomes (7)

  • Length of hospital stay

    through study completion, an average of 1 year

  • Length of intensive care unit stay

    through study completion, an average of 1 year

  • Total amount of chest tube drainage

    through study completion, an average of 1 year

  • Number of additional procedures

    through study completion, an average of 1 year

  • Stroke

    through study completion, an average of 1 year

  • +2 more secondary outcomes

Study Arms (2)

Fenestrated

Standard extracardiac fontan undergoing Fontan fenestration creation

Procedure: Extracardiac FontanProcedure: Fontan fenestration

Non fenestrated

Standard extracardiac fontan without fenestration

Procedure: Extracardiac Fontan

Interventions

Extracardiac Fontan (Total cavo-pulmonary connection) will be constructed with a tube graft from the inferior vena cava to the pulmonary artery \[applied to both arms\]

Also known as: Extracardiac Total cavo-pulmonary connection
FenestratedNon fenestrated

Fontan fenestration created as a single 3 to 6mm communication between fontan channel and pulmonary venous atrium \[Fenestrated arm\]

Fenestrated

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

All patients referred to King Faisal Specialist Hospital and Research Center in Jeddah for an elective (Fontan) Total cavopulmonar connection procedure at the period of the study, who demonstrated a standard risk profile.

You may qualify if:

  • This study will includeall patients referred for an elective TCPC procedure at the period of the study, who demonstrated a standard risk profile
  • Preoperative evaluation consisted of ECG, transthoracic echocardiogram, and complete cardiac catheterization.
  • Patients with the following parameters will be eligible for enrollment in the study:
  • Sinus Rhythm
  • Atriovnetricular valve regurgitation not more than mild
  • Aortic (neoaortic) valve regurgitation not more than mild
  • Normal systolic dominant ventricle function
  • Mean pulmonary artery pressure not more than 15 mmHg (measured directly or estimated by pulmonary vein wedge pressure)
  • Pulmonary vascular resistance not more than 2 woods unit
  • End diastolic ventricular filling pressure not more than 8 mm Hg
  • Patients with pulmonary artery distortion, stenosis or thrombus requiring surgical or interventional additional procedures before or during the Fontan operation.
  • Pacemaker insertion before or during Fontan operation.
  • Significant pulmonary arteriovenous malformations (AVMs) rendering fenestration potentially a cause of excessive cyanosis.
  • Patients for whom the cardiology/cardiac surgery case conference decision is strongly in favor of fenestration for any other cause.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

KFSHRC

Jeddah, Westren, Saudi Arabia

Location

Related Publications (12)

  • Fontan F, Baudet E. Surgical repair of tricuspid atresia. Thorax. 1971 May;26(3):240-8. doi: 10.1136/thx.26.3.240.

    PMID: 5089489BACKGROUND
  • de Leval MR, Kilner P, Gewillig M, Bull C. Total cavopulmonary connection: a logical alternative to atriopulmonary connection for complex Fontan operations. Experimental studies and early clinical experience. J Thorac Cardiovasc Surg. 1988 Nov;96(5):682-95.

    PMID: 3184963BACKGROUND
  • Amodeo A, Galletti L, Marianeschi S, Picardo S, Giannico S, Di Renzi P, Marcelletti C. Extracardiac Fontan operation for complex cardiac anomalies: seven years' experience. J Thorac Cardiovasc Surg. 1997 Dec;114(6):1020-30; discussion 1030-1. doi: 10.1016/S0022-5223(97)70016-3.

    PMID: 9434697BACKGROUND
  • d'Udekem Y, Iyengar AJ, Cochrane AD, Grigg LE, Ramsay JM, Wheaton GR, Penny DJ, Brizard CP. The Fontan procedure: contemporary techniques have improved long-term outcomes. Circulation. 2007 Sep 11;116(11 Suppl):I157-64. doi: 10.1161/CIRCULATIONAHA.106.676445.

    PMID: 17846297BACKGROUND
  • Bando K, Turrentine MW, Park HJ, Sharp TG, Scavo V, Brown JW. Evolution of the Fontan procedure in a single center. Ann Thorac Surg. 2000 Jun;69(6):1873-9. doi: 10.1016/s0003-4975(00)01316-3.

    PMID: 10892940BACKGROUND
  • Azakie A, Russell JL, McCrindle BW, Van Arsdell GS, Benson LN, Coles JG, Williams WG. Anatomic repair of anomalous left coronary artery from the pulmonary artery by aortic reimplantation: early survival, patterns of ventricular recovery and late outcome. Ann Thorac Surg. 2003 May;75(5):1535-41. doi: 10.1016/s0003-4975(02)04822-1.

    PMID: 12735576BACKGROUND
  • de Leval MR, Dubini G, Migliavacca F, Jalali H, Camporini G, Redington A, Pietrabissa R. Use of computational fluid dynamics in the design of surgical procedures: application to the study of competitive flows in cavo-pulmonary connections. J Thorac Cardiovasc Surg. 1996 Mar;111(3):502-13. doi: 10.1016/s0022-5223(96)70302-1.

    PMID: 8601964BACKGROUND
  • Bridges ND, Lock JE, Castaneda AR. Baffle fenestration with subsequent transcatheter closure. Modification of the Fontan operation for patients at increased risk. Circulation. 1990 Nov;82(5):1681-9. doi: 10.1161/01.cir.82.5.1681.

    PMID: 2225370BACKGROUND
  • Bridges ND, Mayer JE Jr, Lock JE, Jonas RA, Hanley FL, Keane JF, Perry SB, Castaneda AR. Effect of baffle fenestration on outcome of the modified Fontan operation. Circulation. 1992 Dec;86(6):1762-9. doi: 10.1161/01.cir.86.6.1762.

    PMID: 1451248BACKGROUND
  • Hsu DT, Quaegebeur JM, Ing FF, Selber EJ, Lamour JM, Gersony WM. Outcome after the single-stage, nonfenestrated Fontan procedure. Circulation. 1997 Nov 4;96(9 Suppl):II-335-40.

    PMID: 9386120BACKGROUND
  • Thompson LD, Petrossian E, McElhinney DB, Abrikosova NA, Moore P, Reddy VM, Hanley FL. Is it necessary to routinely fenestrate an extracardiac fontan? J Am Coll Cardiol. 1999 Aug;34(2):539-44. doi: 10.1016/s0735-1097(99)00228-4.

    PMID: 10440170BACKGROUND
  • Airan B, Sharma R, Choudhary SK, Mohanty SR, Bhan A, Chowdhari UK, Juneja R, Kothari SS, Saxena A, Venugopal P. Univentricular repair: is routine fenestration justified? Ann Thorac Surg. 2000 Jun;69(6):1900-6. doi: 10.1016/s0003-4975(00)01247-9.

    PMID: 10892944BACKGROUND

MeSH Terms

Conditions

Heart Defects, Congenital

Condition Hierarchy (Ancestors)

Cardiovascular AbnormalitiesCardiovascular DiseasesHeart DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • Abdulbadee Bogis, MD

    King Faisal Specialist Hospital & Research Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 9, 2018

First Posted

April 19, 2018

Study Start

April 1, 2023

Primary Completion

April 12, 2023

Study Completion

April 12, 2023

Last Updated

April 18, 2023

Record last verified: 2023-04

Locations